At what enterprise value was SOFTWAY MEDICAL acquired in 2025?

During the acquisition of SOFTWAY MEDICAL by BAIN CAPITAL in 2025, the company was valued at an estimated revenue multiple of 5x - 12x. The transaction's Enterprise Value is estimated to be in the range of 1b - 4b EUR. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the TMT (Tech, Media, Telecom) industry currently tracks an average EBITDA multiple of 14.5x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of SOFTWAY MEDICAL when it was acquired by BAIN CAPITAL?

The estimated EV/EBITDA multiple for SOFTWAY MEDICAL is in the range of Above 20x. For comparison, the TMT (Tech, Media, Telecom) sector currently shows an average EBITDA multiple of 14.5x. Join our community for free to access full valuation data and industry trends.

When was SOFTWAY MEDICAL acquired by BAIN CAPITAL?

SOFTWAY MEDICAL was acquired by BAIN CAPITAL in 2025.

What was the revenue of SOFTWAY MEDICAL at the time of the deal?

The revenue of SOFTWAY MEDICAL at the time of the deal is estimated to be in the range of 100M - 200M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of SOFTWAY MEDICAL during the acquisition?

SOFTWAY MEDICAL's EBITDA is estimated to be in the range of 50M - 100M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the SOFTWAY MEDICAL acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the SOFTWAY MEDICAL deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://capitalfinance.lesechos.fr/deals/lbo/softway-medical-sadosse-a-bain-capital-pour-plus-de-12-mdeur-2161733

← DATABASE

Home Database TMT (Tech, Media, Telecom)SOFTWAY MEDICAL

05/2025

SOFTWAY MEDICAL acquired by BAIN CAPITAL

FRANCE Software / Industry-Specific Software / Healthcare EV 1b - 4b EUR

Context

Bain Capital acquired a majority stake in Softway Medical from Five Arrows and Naxicap Partners, valuing the group at an Enterprise Value (EV) above EUR1.0 billion. This landmark transaction marks a major transition for the French software publisher, aiming to transform a national leader into a pan-European champion. The historical shareholders, Five Arrows and Naxicap, reinvested significantly alongside the management team.

SOFTWAY MEDICAL, which reported an EBITDA margin of in 2024, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the TMT (Tech, Media, Telecom) sector (14.5x).

-> Deep-dive in TMT (Tech, Media, Telecom) market trends

Target

Founded in 1999, Softway Medical is the French leader in cloud-native software solutions for healthcare institutions. The group acts as a publisher, host (HDS certified), and integrator, offering a comprehensive suite of digital tools including Electronic Health Records (EHR) for hospitals, Radiology Information Systems (RIS/PACS), and Laboratory Information Systems (LIS). Its flagship e-Novation platform serves over 1,300 hospitals and clinics (representing a 40% market share in France), 1,300 imaging centers, and 400 laboratories.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2024

2023

Similar deals in Software

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
06/2025	DOCTRINE	DEJURE.ORG	GERMANY	Industry-Specific Software
06/2025	HAWK INFINITY SOFTWARE	DIGISEG	DENMARK	AdTech
05/2025	SALESFORCE INC	INFORMATICA INC	UNITED STATES	Data, Analytics & AI
04/2025	MERITECH CAPITAL PARTNERS / CAPITALG	PENNYLANE	FRANCE	ERP, HR & Finance
04/2025	FTV CAPITAL	N2F	FRANCE	ERP, HR & Finance
04/2025	TA ASSOCIATES	SMARTTRADE TECHNOLOGIES	FRANCE	Financial Services / Banking
03/2025	BAIN CAPITAL	NAMIRIAL	ITALY	Industry-Specific Software
03/2025	TELENOR SOFTWARE / HAWK INFINITY SOFTWARE	JOTTACLOUD	Norway	Software
03/2025	TXT E-SOLUTIONS	IT VALUES	ITALY	Industry-Specific Software
03/2025	EQT PARTNERS	FORTNOX	SWEDEN	ERP, HR & Finance

REFERENCES

Valuation range: EV 1b - 4b EUR

Revenue range: 100M - 200M EUR

EBITDA range: 50M - 100M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of SOFTWAY MEDICAL by BAIN CAPITAL are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: softway medical

Acquirer: bain capital